Davenport & CO LLC Regeneron Pharmaceuticals, Inc. Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 430 shares of REGN stock, worth $306,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares

430

Previous 370 16.22%

Holding current value

$306,332

Previous $388,000 16.49%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$1024.09 - $1201.76 $61,445 - $72,105	60 Added 16.22%	430 $452,000
Q2 2024 Aug 06, 2024	SELL	$883.2 - $1071.19 $72,422 - $87,837	-82 Reduced 18.14%	370 $388,000
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $70,409 - $77,481	78 Added 20.86%	452 $435,000
Q4 2023 Jan 23, 2024	SELL	$775.18 - $881.7 $2,325 - $2,645	-3 Reduced 0.8%	374 $328,000
Q3 2023 Oct 17, 2023	SELL	$692.45 - $844.37 $1.8 Million - $2.2 Million	-2,601 Reduced 87.34%	377 $310,000
Q2 2023 Jul 20, 2023	SELL	$700.03 - $830.35 $657,328 - $779,698	-939 Reduced 23.97%	2,978 $2.14 Million
Q1 2023 Apr 27, 2023	SELL	$680.49 - $826.97 $690,697 - $839,374	-1,015 Reduced 20.58%	3,917 $3.22 Million
Q4 2022 Jan 20, 2023	SELL	$705.89 - $766.39 $63,530 - $68,975	-90 Reduced 1.79%	4,932 $0
Q3 2022 Oct 11, 2022	SELL	$573.97 - $724.32 $28,124 - $35,491	-49 Reduced 0.97%	5,022 $3.46 Million
Q2 2022 Jul 18, 2022	BUY	$548.35 - $738.84 $15,353 - $20,687	28 Added 0.56%	5,071 $3 Million
Q1 2022 May 02, 2022	BUY	$595.12 - $698.43 $144,614 - $169,718	243 Added 5.06%	5,043 $3.52 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $1.15 Million - $1.42 Million	2,121 Added 79.17%	4,800 $3.03 Million
Q3 2021 Oct 14, 2021	BUY	$574.03 - $680.96 $1.23 Million - $1.46 Million	2,141 Added 397.96%	2,679 $1.62 Million
Q2 2021 Jul 28, 2021	BUY	$472.8 - $558.54 $254,366 - $300,494	538 New	538 $300,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account